BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
InSite Vision researchers prepare ophthalmic compositions of oxazolidinones
April 26, 2001
Lumigan introduced following mid-March approval by FDA
April 26, 2001
New PKC activators useful for ocular hypertension, glaucoma, etc.
April 4, 2001
Travatan launch quickly follows first approval in U.S.
April 4, 2001
Lumigan: a potent, long-acting and safe new IOP-lowering drug
April 2, 2001
Recently approved IOP-lowering prostaglandin highlighted at Prague glaucoma meeting
March 29, 2001
ROCK inhibitors investigated for potential as antiglaucoma drugs
March 29, 2001
Expanded use of Visudyne approved in E.U.
March 27, 2001
Iomed and Santen to develop treatment of posterior eye diseases
March 26, 2001
Two new antiglaucoma drugs approved by FDA
March 19, 2001
Previous
1
2
…
355
356
357
358
359
360
361
362
363
…
396
397
Next
RSS